
LINK . SPRINGER . COM {
}
Title:
Latent class analysis of 216 patients with adult-onset Still’s disease | Arthritis Research & Therapy
Description:
Background Adult-onset Still’s disease (AOSD) is a rare systemic autoinflammatory disease which encompasses patients with heterogenous presentation and a wide range of clinical courses. In this study, we aimed to identify potential subgroups of AOSD and reveal risk factors for relapse. Methods We included a total of 216 AOSD patients who received treatment in nine hospitals between 2000 and 2019. All patients fulfilled the Yamaguchi classification criteria. We retrospectively collected information about baseline characteristics, laboratory tests, treatment, relapse, and death. We performed latent class analysis and time-to-event analysis for relapse using the Cox proportional hazard model. Results The median age at disease onset was 51.6 years. The median follow-up period was 36.8 months. At disease onset, 22.3% of the patients had macrophage activation syndrome. The median white blood cell count was 12,600/μL, and the median serum ferritin level was 7230 ng/mL. Systemic corticosteroids were administered in all but three patients (98.6%) and the median initial dosage of prednisolone was 40mg/day. Ninety-six patients (44.4%) were treated with concomitant immunosuppressants, and 22 (10.2%) were treated with biologics. Latent class analysis revealed that AOSD patients were divided into two subgroups: the typical group (Class 1: 71.8%) and the elderly-onset group (Class 2: 28.2%). During the follow-up period, 13 of 216 patients (6.0%) died (12 infections and one senility), and 76 of 216 patients (35.1%) experienced relapses. Overall and relapse-free survival rates at 5 years were 94.9% and 57.3%, respectively, and those rates were not significantly different between Class 1 and 2 (p=0.30 and p=0.19). Time-to-event analysis suggested higher neutrophil count, lower hemoglobin, and age ≥65 years at disease onset as risk factors for death and age ≥65 years at disease onset as a risk factor for relapse. Conclusions AOSD patients were divided into two subgroups: the typical group and the elderly-onset group. Although the survival of patients with AOSD was generally good, the patients often experienced relapses. Age ≥65 years at disease onset was the risk factor for relapse.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We're unsure if the website is profiting.
While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.
Keywords {🔍}
patients, disease, aosd, article, class, study, stills, google, scholar, pubmed, analysis, adultonset, clinical, survival, latent, relapse, table, onset, risk, data, systemic, pattern, cas, treatment, syndrome, median, mas, years, arthritis, age, ferritin, rates, adult, factors, death, group, japan, rheumatol, subgroups, cohort, model, chiba, information, included, received, criteria, characteristics, relapses, relapsefree, chronic,
Topics {✒️}
org/hematology/article/2009/1/127/19872/hemophagocytic-lymphohistiocytosis-hlh article download pdf kaplan-meier survival curve treatment-related adverse events relapse-free survival rates maintain long-term remission life-threatening adult-onset cox regression analysis clinical research centre genome-wide association study c-reactive protein full access catastrophic antiphospholipid syndrome shin-ichiro kagami model selection criteria 1093/rheumatology/keaa904 online ahead macrophage activation syndrome rapid reduction/withdrawal privacy choices/manage cookies thrombotic thrombocytopenic purpura elderly-onset aosd group erythrocyte sedimentation rate latent class analysis latent transition analysis kaplan-meier method multivariate model approach long-term prognosis disseminated intravascular coagulation item response probabilities aosd-related specific complications article sugiyama life-threatening complications relapse-free survival reactive haemophagocytic syndrome elevated liver enzymes reactive hemophagocytic syndrome asahi general hospital long-term treatment creative commons licence pediatr blood cancer higher neutrophil count median initial doses high systemic scores median neutrophil count semin arthritis rheum baseline patient/disease characteristics italian group published elderly-onset group adult haemophagocytic syndrome multicenter retrospective analysis
Schema {🗺️}
WebPage:
mainEntity:
headline:Latent class analysis of 216 patients with adult-onset Still’s disease
description:Adult-onset Still’s disease (AOSD) is a rare systemic autoinflammatory disease which encompasses patients with heterogenous presentation and a wide range of clinical courses. In this study, we aimed to identify potential subgroups of AOSD and reveal risk factors for relapse. We included a total of 216 AOSD patients who received treatment in nine hospitals between 2000 and 2019. All patients fulfilled the Yamaguchi classification criteria. We retrospectively collected information about baseline characteristics, laboratory tests, treatment, relapse, and death. We performed latent class analysis and time-to-event analysis for relapse using the Cox proportional hazard model. The median age at disease onset was 51.6 years. The median follow-up period was 36.8 months. At disease onset, 22.3% of the patients had macrophage activation syndrome. The median white blood cell count was 12,600/μL, and the median serum ferritin level was 7230 ng/mL. Systemic corticosteroids were administered in all but three patients (98.6%) and the median initial dosage of prednisolone was 40mg/day. Ninety-six patients (44.4%) were treated with concomitant immunosuppressants, and 22 (10.2%) were treated with biologics. Latent class analysis revealed that AOSD patients were divided into two subgroups: the typical group (Class 1: 71.8%) and the elderly-onset group (Class 2: 28.2%). During the follow-up period, 13 of 216 patients (6.0%) died (12 infections and one senility), and 76 of 216 patients (35.1%) experienced relapses. Overall and relapse-free survival rates at 5 years were 94.9% and 57.3%, respectively, and those rates were not significantly different between Class 1 and 2 (p=0.30 and p=0.19). Time-to-event analysis suggested higher neutrophil count, lower hemoglobin, and age ≥65 years at disease onset as risk factors for death and age ≥65 years at disease onset as a risk factor for relapse. AOSD patients were divided into two subgroups: the typical group and the elderly-onset group. Although the survival of patients with AOSD was generally good, the patients often experienced relapses. Age ≥65 years at disease onset was the risk factor for relapse.
datePublished:2022-01-03T00:00:00Z
dateModified:2022-01-03T00:00:00Z
pageStart:1
pageEnd:10
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13075-021-02708-3
keywords:
Adult-onset Still’s disease
Macrophage activation syndrome
Latent class analysis
Outcomes
Relapse
Rheumatology
Orthopedics
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13075-021-02708-3/MediaObjects/13075_2021_2708_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13075-021-02708-3/MediaObjects/13075_2021_2708_Fig2_HTML.png
isPartOf:
name:Arthritis Research & Therapy
issn:
1478-6362
volumeNumber:24
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Takahiro Sugiyama
affiliation:
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Shunsuke Furuta
affiliation:
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Masaki Hiraguri
affiliation:
name:Japanese Red Cross Narita Hospital
address:
name:Department of Rheumatology and Allergy, Japanese Red Cross Narita Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Kei Ikeda
affiliation:
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Yosuke Inaba
affiliation:
name:Chiba University Hospital
address:
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Shin-ichiro Kagami
affiliation:
name:Asahi General Hospital
address:
name:Department of Allergy and Clinical Immunology, Asahi General Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Yasuhiko Kita
affiliation:
name:Yokohama Rosai Hospital
address:
name:Department of Rheumatology, Yokohama Rosai Hospital, Yokohama, Japan
type:PostalAddress
type:Organization
type:Person
name:Kei Kobayashi
affiliation:
name:University of Yamanashi
address:
name:Third Department of Internal Medicine, University of Yamanashi, Yamanashi, Japan
type:PostalAddress
type:Organization
type:Person
name:Yoshihisa Kobayashi
affiliation:
name:Chiba Aoba Municipal Hospital
address:
name:Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazuhiro Kurasawa
affiliation:
name:Dokkyo Medical University
address:
name:Department of Rheumatology, Dokkyo Medical University, Tochigi, Japan
type:PostalAddress
type:Organization
type:Person
name:Daiki Nakagomi
affiliation:
name:University of Yamanashi
address:
name:Third Department of Internal Medicine, University of Yamanashi, Yamanashi, Japan
type:PostalAddress
type:Organization
type:Person
name:Yasushi Nawata
affiliation:
name:Chibaken Saiseikai Narashino Hospital
address:
name:Center for Rheumatic Diseases, Chibaken Saiseikai Narashino Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Yohei Kawasaki
affiliation:
name:Chiba University Hospital
address:
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuki Shiko
affiliation:
name:Chiba University Hospital
address:
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Takao Sugiyama
affiliation:
name:National Hospital Organization Shimoshizu Hospital
address:
name:Department of Rheumatology, National Hospital Organization Shimoshizu Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiroshi Nakajima
affiliation:
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Latent class analysis of 216 patients with adult-onset Still’s disease
description:Adult-onset Still’s disease (AOSD) is a rare systemic autoinflammatory disease which encompasses patients with heterogenous presentation and a wide range of clinical courses. In this study, we aimed to identify potential subgroups of AOSD and reveal risk factors for relapse. We included a total of 216 AOSD patients who received treatment in nine hospitals between 2000 and 2019. All patients fulfilled the Yamaguchi classification criteria. We retrospectively collected information about baseline characteristics, laboratory tests, treatment, relapse, and death. We performed latent class analysis and time-to-event analysis for relapse using the Cox proportional hazard model. The median age at disease onset was 51.6 years. The median follow-up period was 36.8 months. At disease onset, 22.3% of the patients had macrophage activation syndrome. The median white blood cell count was 12,600/μL, and the median serum ferritin level was 7230 ng/mL. Systemic corticosteroids were administered in all but three patients (98.6%) and the median initial dosage of prednisolone was 40mg/day. Ninety-six patients (44.4%) were treated with concomitant immunosuppressants, and 22 (10.2%) were treated with biologics. Latent class analysis revealed that AOSD patients were divided into two subgroups: the typical group (Class 1: 71.8%) and the elderly-onset group (Class 2: 28.2%). During the follow-up period, 13 of 216 patients (6.0%) died (12 infections and one senility), and 76 of 216 patients (35.1%) experienced relapses. Overall and relapse-free survival rates at 5 years were 94.9% and 57.3%, respectively, and those rates were not significantly different between Class 1 and 2 (p=0.30 and p=0.19). Time-to-event analysis suggested higher neutrophil count, lower hemoglobin, and age ≥65 years at disease onset as risk factors for death and age ≥65 years at disease onset as a risk factor for relapse. AOSD patients were divided into two subgroups: the typical group and the elderly-onset group. Although the survival of patients with AOSD was generally good, the patients often experienced relapses. Age ≥65 years at disease onset was the risk factor for relapse.
datePublished:2022-01-03T00:00:00Z
dateModified:2022-01-03T00:00:00Z
pageStart:1
pageEnd:10
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13075-021-02708-3
keywords:
Adult-onset Still’s disease
Macrophage activation syndrome
Latent class analysis
Outcomes
Relapse
Rheumatology
Orthopedics
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13075-021-02708-3/MediaObjects/13075_2021_2708_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13075-021-02708-3/MediaObjects/13075_2021_2708_Fig2_HTML.png
isPartOf:
name:Arthritis Research & Therapy
issn:
1478-6362
volumeNumber:24
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Takahiro Sugiyama
affiliation:
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Shunsuke Furuta
affiliation:
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Masaki Hiraguri
affiliation:
name:Japanese Red Cross Narita Hospital
address:
name:Department of Rheumatology and Allergy, Japanese Red Cross Narita Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Kei Ikeda
affiliation:
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Yosuke Inaba
affiliation:
name:Chiba University Hospital
address:
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Shin-ichiro Kagami
affiliation:
name:Asahi General Hospital
address:
name:Department of Allergy and Clinical Immunology, Asahi General Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Yasuhiko Kita
affiliation:
name:Yokohama Rosai Hospital
address:
name:Department of Rheumatology, Yokohama Rosai Hospital, Yokohama, Japan
type:PostalAddress
type:Organization
type:Person
name:Kei Kobayashi
affiliation:
name:University of Yamanashi
address:
name:Third Department of Internal Medicine, University of Yamanashi, Yamanashi, Japan
type:PostalAddress
type:Organization
type:Person
name:Yoshihisa Kobayashi
affiliation:
name:Chiba Aoba Municipal Hospital
address:
name:Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazuhiro Kurasawa
affiliation:
name:Dokkyo Medical University
address:
name:Department of Rheumatology, Dokkyo Medical University, Tochigi, Japan
type:PostalAddress
type:Organization
type:Person
name:Daiki Nakagomi
affiliation:
name:University of Yamanashi
address:
name:Third Department of Internal Medicine, University of Yamanashi, Yamanashi, Japan
type:PostalAddress
type:Organization
type:Person
name:Yasushi Nawata
affiliation:
name:Chibaken Saiseikai Narashino Hospital
address:
name:Center for Rheumatic Diseases, Chibaken Saiseikai Narashino Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Yohei Kawasaki
affiliation:
name:Chiba University Hospital
address:
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuki Shiko
affiliation:
name:Chiba University Hospital
address:
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Takao Sugiyama
affiliation:
name:National Hospital Organization Shimoshizu Hospital
address:
name:Department of Rheumatology, National Hospital Organization Shimoshizu Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiroshi Nakajima
affiliation:
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Arthritis Research & Therapy
issn:
1478-6362
volumeNumber:24
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
name:Japanese Red Cross Narita Hospital
address:
name:Department of Rheumatology and Allergy, Japanese Red Cross Narita Hospital, Chiba, Japan
type:PostalAddress
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
name:Chiba University Hospital
address:
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
type:PostalAddress
name:Asahi General Hospital
address:
name:Department of Allergy and Clinical Immunology, Asahi General Hospital, Chiba, Japan
type:PostalAddress
name:Yokohama Rosai Hospital
address:
name:Department of Rheumatology, Yokohama Rosai Hospital, Yokohama, Japan
type:PostalAddress
name:University of Yamanashi
address:
name:Third Department of Internal Medicine, University of Yamanashi, Yamanashi, Japan
type:PostalAddress
name:Chiba Aoba Municipal Hospital
address:
name:Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan
type:PostalAddress
name:Dokkyo Medical University
address:
name:Department of Rheumatology, Dokkyo Medical University, Tochigi, Japan
type:PostalAddress
name:University of Yamanashi
address:
name:Third Department of Internal Medicine, University of Yamanashi, Yamanashi, Japan
type:PostalAddress
name:Chibaken Saiseikai Narashino Hospital
address:
name:Center for Rheumatic Diseases, Chibaken Saiseikai Narashino Hospital, Chiba, Japan
type:PostalAddress
name:Chiba University Hospital
address:
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
type:PostalAddress
name:Chiba University Hospital
address:
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
type:PostalAddress
name:National Hospital Organization Shimoshizu Hospital
address:
name:Department of Rheumatology, National Hospital Organization Shimoshizu Hospital, Chiba, Japan
type:PostalAddress
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Takahiro Sugiyama
affiliation:
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
name:Shunsuke Furuta
affiliation:
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
email:[email protected]
name:Masaki Hiraguri
affiliation:
name:Japanese Red Cross Narita Hospital
address:
name:Department of Rheumatology and Allergy, Japanese Red Cross Narita Hospital, Chiba, Japan
type:PostalAddress
type:Organization
name:Kei Ikeda
affiliation:
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
name:Yosuke Inaba
affiliation:
name:Chiba University Hospital
address:
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
name:Shin-ichiro Kagami
affiliation:
name:Asahi General Hospital
address:
name:Department of Allergy and Clinical Immunology, Asahi General Hospital, Chiba, Japan
type:PostalAddress
type:Organization
name:Yasuhiko Kita
affiliation:
name:Yokohama Rosai Hospital
address:
name:Department of Rheumatology, Yokohama Rosai Hospital, Yokohama, Japan
type:PostalAddress
type:Organization
name:Kei Kobayashi
affiliation:
name:University of Yamanashi
address:
name:Third Department of Internal Medicine, University of Yamanashi, Yamanashi, Japan
type:PostalAddress
type:Organization
name:Yoshihisa Kobayashi
affiliation:
name:Chiba Aoba Municipal Hospital
address:
name:Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan
type:PostalAddress
type:Organization
name:Kazuhiro Kurasawa
affiliation:
name:Dokkyo Medical University
address:
name:Department of Rheumatology, Dokkyo Medical University, Tochigi, Japan
type:PostalAddress
type:Organization
name:Daiki Nakagomi
affiliation:
name:University of Yamanashi
address:
name:Third Department of Internal Medicine, University of Yamanashi, Yamanashi, Japan
type:PostalAddress
type:Organization
name:Yasushi Nawata
affiliation:
name:Chibaken Saiseikai Narashino Hospital
address:
name:Center for Rheumatic Diseases, Chibaken Saiseikai Narashino Hospital, Chiba, Japan
type:PostalAddress
type:Organization
name:Yohei Kawasaki
affiliation:
name:Chiba University Hospital
address:
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
name:Yuki Shiko
affiliation:
name:Chiba University Hospital
address:
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
name:Takao Sugiyama
affiliation:
name:National Hospital Organization Shimoshizu Hospital
address:
name:Department of Rheumatology, National Hospital Organization Shimoshizu Hospital, Chiba, Japan
type:PostalAddress
type:Organization
name:Hiroshi Nakajima
affiliation:
name:Chiba University Hospital
address:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
name:Department of Rheumatology and Allergy, Japanese Red Cross Narita Hospital, Chiba, Japan
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
name:Department of Allergy and Clinical Immunology, Asahi General Hospital, Chiba, Japan
name:Department of Rheumatology, Yokohama Rosai Hospital, Yokohama, Japan
name:Third Department of Internal Medicine, University of Yamanashi, Yamanashi, Japan
name:Department of Internal Medicine, Chiba Aoba Municipal Hospital, Chiba, Japan
name:Department of Rheumatology, Dokkyo Medical University, Tochigi, Japan
name:Third Department of Internal Medicine, University of Yamanashi, Yamanashi, Japan
name:Center for Rheumatic Diseases, Chibaken Saiseikai Narashino Hospital, Chiba, Japan
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
name:Biostatistics Section, Clinical Research Centre, Chiba University Hospital, Chiba, Japan
name:Department of Rheumatology, National Hospital Organization Shimoshizu Hospital, Chiba, Japan
name:Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan
External Links {🔗}(174)
- Discover the revenue of https://www.springernature.com/gp/authors
- What is the monthly revenue of https://link.springernature.com/home/?
- How much cash flow does https://order.springer.com/public/cart have monthly?
- What's the profit of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- What are the total earnings of https://arthritis-research.biomedcentral.com/about?
- Find out how much https://submission.nature.com/new-submission/13075/3 earns monthly
- What's the financial outcome of https://doi.org/10.1016%2Fj.autrev.2014.01.058?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24657513?
- How much does http://scholar.google.com/scholar_lookup?&title=Adult-onset%20Still%E2%80%99s%20disease&journal=Autoimmun%20Rev&doi=10.1016%2Fj.autrev.2014.01.058&volume=13&pages=708-722&publication_year=2014&author=Gerfaud-Valentin%2CM&author=Jamilloux%2CY&author=Iwaz%2CJ&author=Seve%2CP gross monthly?
- https://doi.org/10.1111%2Fj.1742-1241.2007.01393.x's revenue stream
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17511792?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Adult-onset%20Still%E2%80%99s%20disease&journal=Int%20J%20Clin%20Pract&doi=10.1111%2Fj.1742-1241.2007.01393.x&volume=63&pages=1050-1055&publication_year=2009&author=Cagatay%2CY&author=Gul%2CA&author=Cagatay%2CA&author=Kamali%2CS&author=Karadeniz%2CA&author=Inanc%2CM
- How much revenue does https://doi.org/10.1016%2FS0002-9343%2899%2980318-0 generate?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7709952's financial summary
- http://scholar.google.com/scholar_lookup?&title=A%20controlled%20study%20of%20the%20long-term%20prognosis%20of%20adult%20Still%E2%80%99s%20disease&journal=Am%20J%20Med&doi=10.1016%2FS0002-9343%2899%2980318-0&volume=98&pages=384-388&publication_year=1995&author=Sampalis%2CJS&author=Esdaile%2CJM&author=Medsger%2CTA&author=Partridge%2CAJ&author=Yeadon%2CC&author=Senecal%2CJL's financial summary
- How much does https://doi.org/10.1177%2F095952879708000106 pull in monthly?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20896907?
- Get to know http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2036674's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=On%20a%20form%20of%20chronic%20joint%20disease%20in%20children&journal=Med%20Chir%20Trans&doi=10.1177%2F095952879708000106&volume=80&pages=47-60.9&publication_year=1897&author=Still%2CGF pull in?
- Learn about the earnings of https://doi.org/10.1136%2Fard.30.2.121
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=5315135?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1005739?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Still%E2%80%99s%20disease%20in%20the%20adult&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.30.2.121&volume=30&issue=2&pages=121-133&publication_year=1971&author=Bywaters%2CEG?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20549276 rake in every month?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Clinical%20features%20and%20prognosis%20in%20adult-onset%20Still%E2%80%99s%20disease%3A%20a%20study%20of%20104%20cases&journal=Clin%20Rheumatol&doi=10.1007%2Fs10067-010-1516-1&volume=29&pages=1015-1019&publication_year=2010&author=Kong%2CXD&author=Xu%2CD&author=Zhang%2CW&author=Zhao%2CY&author=Zeng%2CX&author=Zhang%2CF making per month?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24050706 generate?
- http://scholar.google.com/scholar_lookup?&title=Clinical%20features%20and%20prognosis%20in%2082%20patients%20with%20adult-onset%20Still%E2%80%99s%20disease&journal=Clin%20Exp%20Rheumatol&volume=32&pages=28-33&publication_year=2014&author=Kim%2CYJ&author=Koo%2CBS&author=Kim%2CYG&author=Lee%2CCK&author=Yoo%2CB's financial summary
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24737284
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Cutaneous%20manifestations%20of%20adult-onset%20Still%27s%20disease%3A%20a%20case%20report%20and%20review%20of%20literature&journal=Clin%20Rheumatol&doi=10.1007%2Fs10067-014-2614-2&volume=35&pages=1377-1382&publication_year=2016&author=Cozzi%2CA&author=Papagrigoraki%2CA&author=Biasi%2CD&author=Colato%2CC&author=Girolomoni%2CG?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16365690 generate?
- Revenue of http://scholar.google.com/scholar_lookup?&title=A%20multicenter%20study%20of%20patients%20with%20adult-onset%20Still%E2%80%99s%20disease%20compared%20with%20systemic%20juvenile%20idiopathic%20arthritis&journal=Clin%20Rheumatol&doi=10.1007%2Fs10067-005-0138-5&volume=25&pages=639-644&publication_year=2006&author=Pay%2CS&author=Turkcapar%2CN&author=Kalyoncu%2CM&author=Simsek%2CI&author=Beyan%2CE&author=Ertenli%2CI
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11246670 earning monthly?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Diagnostic%20value%20of%20ferritin%20and%20glycosylated%20ferritin%20in%20adult%20onset%20Still%E2%80%99s%20disease&journal=J%20Rheumatol&volume=28&pages=322-329&publication_year=2001&author=Fautrel%2CB&author=Moel%2CG&author=Saint-Marcoux%2CB&author=Taupin%2CP&author=Vignes%2CS&author=Rozenberg%2CS?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23968282 bring in each month?
- What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751883?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=The%20hyperferritinemic%20syndrome%3A%20macrophage%20activation%20syndrome%2C%20Still%E2%80%99s%20disease%2C%20septic%20shock%20and%20catastrophic%20antiphospholipid%20syndrome&journal=BMC%20Med&doi=10.1186%2F1741-7015-11-185&volume=11&publication_year=2013&author=Ros%C3%A1rio%2CC&author=Zandman-Goddard%2CG&author=Meyron-Holtz%2CEG&author=D%E2%80%99Cruz%2CDP&author=Shoenfeld%2CY?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25388963?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Pathogenesis%20of%20adult-onset%20Still%E2%80%99s%20disease%3A%20new%20insights%20from%20the%20juvenile%20counterpart&journal=Immunol%20Res&doi=10.1007%2Fs12026-014-8561-9&volume=61&pages=53-62&publication_year=2015&author=Jamilloux%2CY&author=Gerfaud-Valentin%2CM&author=Martinon%2CF&author=Belot%2CA&author=Henry%2CT&author=Seve%2CP generate?
- How much money does https://doi.org/10.1016%2Fj.semarthrit.2019.04.004 generate?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=31109638?
- http://scholar.google.com/scholar_lookup?&title=Racial%2FEthnic%20variations%20in%20morbidity%20and%20mortality%20in%20Adult%20Onset%20Still%E2%80%99s%20Disease%3A%20an%20analysis%20of%20national%20dataset&journal=Semin%20Arthritis%20Rheum&doi=10.1016%2Fj.semarthrit.2019.04.004&volume=49&pages=469-473&publication_year=2019&author=Mehta%2CBY&author=Ibrahim%2CS&author=Briggs%2CW&author=Efthimiou%2CP's financial summary
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27502500 generate monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=Epidemiological%20study%20of%20adult-onset%20Still%E2%80%99s%20disease%20using%20a%20Japanese%20administrative%20database&journal=Rheumatol%20Int&doi=10.1007%2Fs00296-016-3546-8&volume=36&pages=1399-1405&publication_year=2016&author=Sakata%2CN&author=Shimizu%2CS&author=Hirano%2CF&author=Fushimi%2CK earning monthly?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24435354 generate?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102228 earn?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Life-threatening%20complications%20of%20adult-onset%20Still%E2%80%99s%20disease&journal=Clin%20Rheumatol&doi=10.1007%2Fs10067-014-2487-4&volume=33&pages=305-314&publication_year=2014&author=Efthimiou%2CP&author=Kadavath%2CS&author=Mehta%2CB?
- Earnings of https://doi.org/10.1136%2Fard.2005.046904
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16540551?
- How much income is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1798476 earning monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Reactive%20haemophagocytic%20syndrome%20in%20adult-onset%20Still%E2%80%99s%20disease%3A%20a%20report%20of%20six%20patients%20and%20a%20review%20of%20the%20literature&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fard.2005.046904&volume=65&pages=1596-1601&publication_year=2006&author=Arlet%2CJB&author=Le%2CTH&author=Marinho%2CA&author=Amoura%2CZ&author=Wechsler%2CB&author=Papo%2CT pull in?
- How much revenue does https://doi.org/10.1016%2FS0140-6736%2813%2961048-X bring in?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24290661?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Adult%20haemophagocytic%20syndrome&journal=Lancet&doi=10.1016%2FS0140-6736%2813%2961048-X&volume=383&pages=1503-1516&publication_year=2014&author=Ramos-Casals%2CM&author=Brito-Zer%C3%B3n%2CP&author=L%C3%B3pez-Guillermo%2CA&author=Khamashta%2CMA&author=Bosch%2CX
- How much income is https://doi.org/10.1002%2Fart.38672 earning monthly?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Clinical%20characteristics%20and%20treatment%20outcomes%20of%20autoimmune-associated%20hemophagocytic%20syndrome%20in%20adults&journal=Arthritis%20Rheum&doi=10.1002%2Fart.38672&volume=66&pages=2297-2307&publication_year=2014&author=Kumakura%2CS&author=Murakawa%2CY
- Revenue of https://doi.org/10.1097%2F01.SMJ.0000047763.56451.F0
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12602713 earn?
- How much does http://scholar.google.com/scholar_lookup?&title=Chronic%20relapsing%20thrombotic%20thrombocytopenic%20purpura%20in%20adult%20onset%20Still%E2%80%99s%20disease&journal=South%20Med%20J&doi=10.1097%2F01.SMJ.0000047763.56451.F0&volume=96&pages=46-49&publication_year=2003&author=Perez%2CMG&author=Rodwig%2CFR pull in monthly?
- Get to know https://doi.org/10.1097%2FMAJ.0b013e318191436e's earnings
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19322066?
- http://scholar.google.com/scholar_lookup?&title=Thrombotic%20thrombocytopenic%20purpura%20and%20adult%20onset%20Still%E2%80%99s%20disease&journal=Am%20J%20Med%20Sci&doi=10.1097%2FMAJ.0b013e318191436e&volume=337&pages=373-376&publication_year=2009&author=Gopal%2CM&author=Cohn%2CCD&author=McEntire%2CMR&author=Alperin%2CJB income
- Income figures for https://doi.org/10.1182%2Fblood-2003-11-4035
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14982878 generate monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Effect%20of%20plasma%20exchange%20on%20plasma%20ADAMTS13%20metalloprotease%20activity%2C%20inhibitor%20level%2C%20and%20clinical%20outcome%20in%20patients%20with%20idiopathic%20and%20nonidiopathic%20thrombotic%20thrombocytopenic%20purpura&journal=Blood.&doi=10.1182%2Fblood-2003-11-4035&volume=103&pages=4043-4049&publication_year=2004&author=Zheng%2CXL&author=Kaufman%2CRM&author=Goodnough%2CLT&author=Sadler%2CJE pull in monthly?
- Learn about the earnings of https://doi.org/10.1097%2F00063198-199909000-00007
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10461535?
- See how much http://scholar.google.com/scholar_lookup?&title=Pulmonary%20involvement%20in%20adult-onset%20Still%E2%80%99s%20disease&journal=Curr%20Opin%20Pulm%20Med&doi=10.1097%2F00063198-199909000-00007&volume=5&pages=305-309&publication_year=1999&author=Cheema%2CGS&author=Quismorio%2CFP makes per month
- What are the total earnings of https://doi.org/10.1002%2Fart.1780300209?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Adult-onset%20Still%E2%80%99s%20disease.%20Clinical%20course%20and%20outcome&journal=Arthr%20Rheum&doi=10.1002%2Fart.1780300209&volume=30&pages=186-194&publication_year=1987&author=Cush%2CJJ&author=Medsger%2CTA&author=Christy%2CWC&author=Herbert%2CDC&author=Cooperstein%2CLA
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1578458
- http://scholar.google.com/scholar_lookup?&title=Preliminary%20criteria%20for%20classification%20of%20adult%20Still%27s%20disease&journal=J%20Rheumatol&volume=19&pages=424-430&publication_year=1992&author=Yamaguchi%2CM&author=Ohta%2CA&author=Tsunematsu%2CT&author=Kasukawa%2CR&author=Mizushima%2CY&author=Kashiwagi%2CH's revenue stream
- What's the monthly income of https://ashpublications.org/hematology/article/2009/1/127/19872/Hemophagocytic-lymphohistiocytosis-HLH-and-related?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1992521
- How much does http://scholar.google.com/scholar_lookup?&title=Diagnostic%20guidelines%20for%20hemophagocytic%20lymphohistiocytosis.%20The%20FHL%20Study%20Group%20of%20the%20Histiocyte%20Society&journal=Semin%20Oncol&volume=18&pages=29-33&publication_year=1991&author=Henter%2CJI&author=Elinder%2CG&author=Ost%2CA pull in?
- Discover the revenue of https://doi.org/10.1002%2Fpbc.21039
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16937360 produce monthly?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=HLH-2004%3A%20diagnostic%20and%20therapeutic%20guidelines%20for%20hemophagocytic%20lymphohistiocytosis&journal=Pediatr%20Blood%20Cancer&doi=10.1002%2Fpbc.21039&volume=48&pages=124-131&publication_year=2007&author=Henter%2CJI&author=Horne%2CA&author=Arico%2CM&author=Egeler%2CRM&author=Filipovich%2CAH&author=Imashuku%2CS?
- Get to know what's the income of https://doi.org/10.1002%2Fart.38690
- How much income is http://scholar.google.com/scholar_lookup?&title=Development%20and%20validation%20of%20the%20HScore%2C%20a%20score%20for%20the%20diagnosis%20of%20reactive%20hemophagocytic%20syndrome&journal=Arthritis%20Rheum&doi=10.1002%2Fart.38690&volume=66&pages=2613-2620&publication_year=2014&author=Fardet%2CL&author=Galicier%2CL&author=Lambotte%2CO&author=Marzac%2CC&author=Aumont%2CC&author=Chahwan%2CD earning monthly?
- What's the income of https://doi.org/10.1097%2F00005792-199103000-00004?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Adult%20Still%E2%80%99s%20disease%3A%20manifestations%2C%20disease%20course%2C%20and%20outcome%20in%2062%20patients&journal=Medicine%20%28Baltimore%29&doi=10.1097%2F00005792-199103000-00004&volume=70&pages=118-136&publication_year=1991&author=Pouchot%2CJ&author=Sampalis%2CJS&author=Beaudet%2CF&author=Carette%2CS&author=D%C3%A9cary%2CF&author=Salusinsky-Sternbach%2CM is on a monthly basis
- What's https://doi.org/10.1016%2Fj.semarthrit.2010.12.006's gross income?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21377714
- How much income is http://scholar.google.com/scholar_lookup?&title=The%20evolution%20of%20adult-onset%20Still%20disease%3A%20an%20observational%20and%20comparative%20study%20in%20a%20cohort%20of%2076%20Italian%20patients&journal=Semin%20Arthritis%20Rheum&doi=10.1016%2Fj.semarthrit.2010.12.006&volume=41&pages=279-285&publication_year=2011&author=Colina%2CM&author=Zucchini%2CW&author=Ciancio%2CG&author=Orzincolo%2CC&author=Trotta%2CF&author=Govoni%2CM earning monthly?
- Monthly income for https://doi.org/10.1002%2F9780470567333
- How much profit does http://scholar.google.com/scholar_lookup?&title=Latent%20class%20and%20latent%20transition%20analysis%3A%20with%20applications%20in%20the%20social%2C%20behavioral%2C%20and%20health%20sciences&doi=10.1002%2F9780470567333&publication_year=2009&author=Collins%2CLM&author=Lanza%2CST make?
- https://doi.org/10.1080%2F10705510701575602's revenue stream
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=PROC%20LCA%3A%20a%20SAS%20procedure%20for%20latent%20class%20analysis&journal=Struct%20Equ%20Model%20Multidiscip%20J&doi=10.1080%2F10705510701575602&volume=14&pages=671-694&publication_year=2007&author=Lanza%2CST&author=Collins%2CLM&author=Lemmon%2CDR&author=Schafer%2CJL?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27903264's gross income?
- Explore the financials of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131497
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Adult-onset%20Still%E2%80%99s%20disease%3A%20evaluation%20of%20prognostic%20tools%20and%20validation%20of%20the%20systemic%20score%20by%20analysis%20of%20100%20cases%20from%20three%20centers&journal=BMC%20Med&doi=10.1186%2Fs12916-016-0738-8&volume=14&publication_year=2016&author=Ruscitti%2CP&author=Cipriani%2CP&author=Masedu%2CF&author=Iacono%2CD&author=Ciccia%2CF&author=Liakouli%2CV
- What's the monthly money flow for https://doi.org/10.1097%2FMD.0000000000000451?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Reactive%20hemophagocytic%20syndrome%20in%20adult-onset%20Still%20disease%3A%20clinical%20features%2C%20predictive%20factors%2C%20and%20prognosis%20in%2021%20patients&journal=Medicine%20%28Baltimore%29&doi=10.1097%2FMD.0000000000000451&volume=94&publication_year=2015&author=Bae%2CCB&author=Jung%2CJY&author=Kim%2CHA&author=Suh%2CCH?
- https://doi.org/10.3899%2Fjrheum.170955's financial summary
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29657144?
- http://scholar.google.com/scholar_lookup?&title=Macrophage%20activation%20syndrome%20in%20patients%20affected%20by%20adult-onset%20still%20disease%3A%20analysis%20of%20survival%20rates%20and%20predictive%20factors%20in%20the%20Gruppo%20Italiano%20di%20Ricerca%20in%20Reumatologia%20Clinica%20e%20Sperimentale%20Cohort&journal=J%20Rheumatol&doi=10.3899%2Fjrheum.170955&volume=45&pages=864-872&publication_year=2018&author=Ruscitti%2CP&author=Iacono%2CD&author=Ciccia%2CF&author=Emmi%2CG&author=Cipriani%2CP&author=Grembiale%2CRD income
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21274538 generate?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Therapeutic%20responses%20and%20prognosis%20in%20adult-onset%20Still%E2%80%99s%20disease&journal=Rheumatol%20Int&doi=10.1007%2Fs00296-011-1801-6&volume=32&pages=1291-1298&publication_year=2012&author=Kim%2CHA&author=Sung%2CJM&author=Suh%2CCH earns monthly
- Monthly income for https://doi.org/10.3109%2F14397595.2014.974881
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25382730
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Nationwide%20epidemiological%20survey%20of%20169%20patients%20with%20adult%20Still%E2%80%99s%20disease%20in%20Japan&journal=Mod%20Rheumatol&doi=10.3109%2F14397595.2014.974881&volume=25&pages=393-400&publication_year=2015&author=Asanuma%2CYF&author=Mimura%2CT&author=Tsuboi%2CH&author=Noma%2CH&author=Miyoshi%2CF&author=Yamamoto%2CK is on a monthly basis
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32130578
- How much does http://scholar.google.com/scholar_lookup?&title=Macrophage%20activation%20syndrome%20associated%20with%20adult-onset%20Still%E2%80%99s%20disease%3A%20a%20multicenter%20retrospective%20analysis&journal=Clin%20Rheumatol&doi=10.1007%2Fs10067-020-04949-0&volume=39&pages=2379-2386&publication_year=2020&author=Wang%2CR&author=Li%2CT&author=Ye%2CS&author=Tan%2CW&author=Zhao%2CC&author=Li%2CY earn?
- How much does https://doi.org/10.1136%2Fannrheumdis-2018-214635 earn?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30389689's revenue stream
- How much profit does http://scholar.google.com/scholar_lookup?&title=Tocilizumab%20in%20patients%20with%20adult-onset%20Still%E2%80%99s%20disease%20refractory%20to%20glucocorticoid%20treatment&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2018-214635&volume=78&publication_year=2019&author=Lee%2CYH make?
- How much does https://doi.org/10.1093%2Frheumatology%2Fkez622 pull in?
- How much income is http://scholar.google.com/scholar_lookup?&title=Clinical%20characteristics%20and%20comorbidities%20in%20adult-onset%20Still%E2%80%99s%20disease%20using%20a%20large%20US%20administrative%20claims%20database&journal=Rheumatology%20%28Oxford%29&doi=10.1093%2Frheumatology%2Fkez622&volume=59&pages=1725-1733&publication_year=2020&author=Lenert%2CA&author=Oh%2CG&author=Ombrello%2CMJ&author=Kim%2CS earning monthly?
- Earnings of https://doi.org/10.1093/rheumatology/keaa904
- Monthly income for https://doi.org/10.3109%2F14397595.2013.850998
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24252024
- Revenue of http://scholar.google.com/scholar_lookup?&title=Clinical%20value%20of%20%281%29%288%29F-fluoro-dexoxyglucose%20positron%20emission%20tomography%2Fcomputed%20tomography%20in%20patients%20with%20adult-onset%20Still%E2%80%99s%20disease%3A%20a%20seven-case%20series%20and%20review%20of%20the%20literature&journal=Mod%20Rheumatol&doi=10.3109%2F14397595.2013.850998&volume=24&pages=645-650&publication_year=2014&author=Yamashita%2CH&author=Kubota%2CK&author=Takahashi%2CY&author=Minamimoto%2CR&author=Morooka%2CM&author=Kaneko%2CH
- How much money does https://doi.org/10.1016%2Fj.autrev.2014.08.032 generate?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25183244 make?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Adult%20onset%20Still%27s%20disease%20%28AOSD%29%20in%20the%20era%20of%20biologic%20therapies%3A%20dichotomous%20view%20for%20cytokine%20and%20clinical%20expressions&journal=Autoimmun%20Rev&doi=10.1016%2Fj.autrev.2014.08.032&volume=13&pages=1149-1159&publication_year=2014&author=Maria%2CAT&author=Quellec%2CA&author=Jorgensen%2CC&author=Touitou%2CI&author=Rivi%C3%A8re%2CS&author=Guilpain%2CP generate?
- https://doi.org/10.1136%2Fannrheumdis-2020-217155's total income per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=32404342 generate monthly?
- http://scholar.google.com/scholar_lookup?&title=Canakinumab%20for%20Treatment%20of%20Adult-Onset%20Still%E2%80%99s%20Disease%20to%20Achieve%20Reduction%20of%20Arthritic%20Manifestation%20%28CONSIDER%29%3A%20phase%20II%2C%20randomised%2C%20double-blind%2C%20placebo-controlled%2C%20multicentre%2C%20investigator-initiated%20trial&journal=Ann%20Rheum%20Dis&doi=10.1136%2Fannrheumdis-2020-217155&volume=79&pages=1090-1097&publication_year=2020&author=Kedor%2CC&author=Listing%2CJ&author=Zernicke%2CJ&author=Weiss%2CA&author=Behrens%2CF&author=Blank%2CN's total income per month
- How much income is https://doi.org/10.1002%2Facr.21901 earning monthly?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Anakinra%20in%20adult-onset%20Still%E2%80%99s%20disease%3A%20long-term%20treatment%20in%20patients%20resistant%20to%20conventional%20therapy&journal=Arthritis%20Care%20Res&doi=10.1002%2Facr.21901&volume=65&pages=822-826&publication_year=2013&author=Giampietro%2CC&author=Ridene%2CM&author=Lequerre%2CT&author=Costedoat%20Chalumeau%2CN&author=Amoura%2CZ&author=Sellam%2CJ?
- What's the financial gain of https://citation-needed.springer.com/v2/references/10.1186/s13075-021-02708-3?format=refman&flavour=references?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takahiro%20Sugiyama make?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takahiro%20Sugiyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's financial summary
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shunsuke%20Furuta
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shunsuke%20Furuta%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Masaki%20Hiraguri earns monthly
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Masaki%20Hiraguri%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kei%20Ikeda?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kei%20Ikeda%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yosuke%20Inaba?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yosuke%20Inaba%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shin-ichiro%20Kagami generate?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shin-ichiro%20Kagami%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yasuhiko%20Kita
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yasuhiko%20Kita%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kei%20Kobayashi earns monthly
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kei%20Kobayashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yoshihisa%20Kobayashi
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yoshihisa%20Kobayashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kazuhiro%20Kurasawa earns monthly
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kazuhiro%20Kurasawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Daiki%20Nakagomi
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Daiki%20Nakagomi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yasushi%20Nawata each month?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yasushi%20Nawata%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yohei%20Kawasaki?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yohei%20Kawasaki%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuki%20Shiko's financial summary
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuki%20Shiko%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takao%20Sugiyama produce monthly?
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takao%20Sugiyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hiroshi%20Nakajima
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hiroshi%20Nakajima%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much cash flow does https://static-content.springer.com/esm/art%3A10.1186%2Fs13075-021-02708-3/MediaObjects/13075_2021_2708_MOESM1_ESM.docx have monthly?
- How much income is http://creativecommons.org/licenses/by/4.0/ earning monthly?
- Financial intake of http://creativecommons.org/publicdomain/zero/1.0/
- What's the income generated by https://s100.copyright.com/AppDispatchServlet?title=Latent%20class%20analysis%20of%20216%20patients%20with%20adult-onset%20Still%E2%80%99s%20disease&author=Takahiro%20Sugiyama%20et%20al&contentID=10.1186%2Fs13075-021-02708-3©right=The%20Author%28s%29&publication=1478-6362&publicationDate=2022-01-03&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0 each month?
- How much money does https://crossmark.crossref.org/dialog/?doi=10.1186/s13075-021-02708-3 generate?
- What's https://citation-needed.springer.com/v2/references/10.1186/s13075-021-02708-3?format=refman&flavour=citation's gross income?
- Get to know what's the income of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- How much does https://www.springernature.com/gp/products rake in every month?
- See how much https://www.springernature.com/gp/librarians makes per month
- https://www.springernature.com/gp/societies income
- How much profit does https://www.springernature.com/gp/partners generate?
- Financial intake of https://www.springer.com/
- https://www.nature.com/'s financial summary
- What's the financial outcome of https://www.biomedcentral.com/?
- Financial intake of https://www.palgrave.com/
- How much income does https://www.apress.com/ have?
- What's https://www.springernature.com/gp/legal/ccpa's gross income?
- What's the income generated by https://www.springernature.com/gp/info/accessibility each month?
- https://support.springernature.com/en/support/home's financial summary
- How much income is https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations earning monthly?
- Financial intake of https://www.springernature.com/
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref